Search
forResearch 10 of 1000+
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Management of Toxicities of Targeted Therapies
- Effects of local and systemic medications on eye health: Adverse reactions
- Dermatological adverse events with taxane chemotherapy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Séquelles cutanéomuqueuses et oculaires des SJS et de Lyell
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
Community 10 of 30
- Eye bags from topical minoxidil — what actually worked for you?
- Topical latanoprost chance of eye color change?
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Minoxidil Eye Bags and Dark Circles
- Severe dry eye: finasteride vs dutasteride
- Any remedy for eye bags from minoxidil 5%?
- How common are dark eye circles / wrinkles with Minoxidil?
- Minoxidil causes eye issues as per this article
- Finasteride / Dutasteride and myopia progression or eye issues?
- Finasteride and Eye Problems: You’re Not Going Crazy
Learn
— no results
Try a deeper search in learn →